Advanced in Metabolic Syndrome

Qing G. Su

1665, Kong Jiang Road, 
Shanghai, CN 
Advanced in Metabolic Syndrome
1665, Kong Jiang Road, 
Shanghai, CN 
OverviewLocationsClinical Research

Overview

Qing Su practices in Shanghai, China. Ms. Su is rated as an Advanced expert by MediFind in the treatment of Metabolic Syndrome. Her top areas of expertise are Type 2 Diabetes (T2D), Hypertension, Metabolic Syndrome, and Abdominal Obesity Metabolic Syndrome.

Her clinical research consists of co-authoring 362 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 16 articles in the study of Metabolic Syndrome.

Gender
Female

Locations

1665, Kong Jiang Road, Shanghai, 200092, China
Other Locations
197 Rui Jin 2nd Road, Shanghai, 200025, China
No.1023, South Shatai Road, Guangzhou, 510515, China
2699 Qianjin Street, Changchun, 130012, China
548 Binwen Road, Hangzhou, 310053, China
1665 Kongjiang Road, Yangpu, China
Key Laboratory Of Environment And Genes Related To Diseases, Xi'an, 710061, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Prospective, Randomized, Double-Blind Comparison of LY900014 to Insulin Lispro in Combination With Insulin Glargine or Insulin Degludec in Adults With Type 1 Diabetes
A Prospective, Randomized, Double-Blind Comparison of LY900014 to Insulin Lispro in Combination With Insulin Glargine or Insulin Degludec in Adults With Type 1 Diabetes
Enrollment Status: Completed
Publish Date: February 08, 2023
Intervention Type: Drug
Study Drugs: LY900014, Insulin Lispro, Insulin Glargine, Insulin Degludec
Study Phase: Phase 3
Phase III Study of Chiglitazar in Patients With Type 2 Diabetes Mellitus and Insufficient Glycemic Control Despite Diet and Exercise -- A Multicenter, Randomized, Double-Blind, and Placebo-Controlled Trial
Phase III Study of Chiglitazar in Patients With Type 2 Diabetes Mellitus and Insufficient Glycemic Control Despite Diet and Exercise -- A Multicenter, Randomized, Double-Blind, and Placebo-Controlled Trial
Enrollment Status: Completed
Publish Date: October 25, 2019
Intervention Type: Drug
Study Phase: Phase 3
View 1 Less Clinical Trial

362 Total Publications

SO2 Capture and Separation: Adsorption Performance and Mechanism of the Amino-Modified UiO-67 Metal-Organic Framework.
SO2 Capture and Separation: Adsorption Performance and Mechanism of the Amino-Modified UiO-67 Metal-Organic Framework.
Journal: Inorganic chemistry
Published: October 03, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Su's expertise for a condition
ConditionClose
    View All 65 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile